Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Prim. 2019;5:66.

PubMed  Article  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

PubMed  Article  Google Scholar 

Lee KL, Kuo YC, Ho YS, Huang YH. Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness. Cancers (Basel). 2019;11:1334.

CAS  Article  Google Scholar 

Lv Y, Ma X, Du Y, Feng J. Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets. Onco Targets Ther. 2021;14:589–607.

PubMed  PubMed Central  Article  Google Scholar 

Camorani S, Fedele M, Zannetti A, Cerchia L. TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities. Pharm (Basel). 2018;11:123.

CAS  Article  Google Scholar 

Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer. 2009;9:785–97.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Johnson J, Thijssen B, McDermott U, Garnett M, Wessels LF, Bernards R. Targeting the RB-E2F pathway in breast cancer. Oncogene. 2016;35:4829–35.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bernards R, Weinberg RA. A progression puzzle. Nature. 2002;418:823.

CAS  PubMed  Article  Google Scholar 

Yuwanita I, Barnes D, Monterey MD, O’Reilly S, Andrechek ER. Increased metastasis with loss of E2F2 in Myc-driven tumors. Oncotarget. 2015;6:38210–24.

PubMed  PubMed Central  Article  Google Scholar 

Yuwanita I, Barnes D, Monterey MD, O’Reilly S, Andrechek ER. Increased metastasis with loss of E2F2 in Myc-driven tumors. Oncotarget. 2015;6:38210–24.

PubMed  PubMed Central  Article  Google Scholar 

Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.

CAS  PubMed  Article  Google Scholar 

Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29:4741–51.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69–84.

CAS  PubMed  Article  Google Scholar 

Arima Y, Hayashi H, Sasaki M, Hosonaga M, Goto TM, Chiyoda T, et al. Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer. J Biol Chem. 2012;287:7896–906.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Montserrat N, Gallardo A, Escuin D, Catasus L, Prat J, Gutiérrez-Avignó FJ, et al. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort? Hum Pathol. 2011;42:103–10.

CAS  PubMed  Article  Google Scholar 

Sajjad N, Mir MM, Khan J, Rather IA, Bhat EA. Recognition of TRAIP with TRAFs: Current understanding and associated diseases. Int J Biochem Cell Biol. 2019;115:105589.

CAS  PubMed  Article  Google Scholar 

Park IS, Han YG, Chung HJ, Jung YW, Kim Y, Kim H. SUMOylation regulates nuclear localization and stability of TRAIP/RNF206. Biochem Biophys Res Commun. 2016;470:881–7.

CAS  PubMed  Article  Google Scholar 

Chapard C, Hohl D, Huber M. The role of the TRAF-interacting protein in proliferation and differentiation. Exp Dermatol. 2012;21:321–6.

CAS  PubMed  Article  Google Scholar 

Harley ME, Murina O, Leitch A, Higgs MR, Bicknell LS, Yigit G, et al. TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism. Nat Genet. 2016;48:36–43.

CAS  PubMed  Article  Google Scholar 

Chapard C, Hohl D, Huber M. The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis. Oncotarget. 2015;6:20933–45.

PubMed  PubMed Central  Article  Google Scholar 

Merkle JA, Rickmyre JL, Garg A, Loggins EB, Jodoin JN, Lee E, et al. no poles encodes a predicted E3 ubiquitin ligase required for early embryonic development of Drosophila. Development. 2009;136:449–59.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chapard C, Meraldi P, Gleich T, Bachmann D, Hohl D, Huber M. TRAIP is a regulator of the spindle assembly checkpoint. J Cell Sci. 2014;127:5149–56.

PubMed  Google Scholar 

Park IS, Jo KS, Won HS, Kim H. Dimerization of TRAF-interacting protein (TRAIP) regulates the mitotic progression. Biochem Biophys Res Commun. 2015;463:864–9.

CAS  PubMed  Article  Google Scholar 

Park ES, Choi S, Kim JM, Jeong Y, Choe J, Park CS, et al. Early embryonic lethality caused by targeted disruption of the TRAF-interacting protein (TRIP) gene. Biochem Biophys Res Commun. 2007;363:971–7.

CAS  PubMed  Article  Google Scholar 

Chapard C, Hohl D, Huber M. The role of the TRAF-interacting protein in proliferation and differentiation. Exp Dermatol. 2012;21:321–6.

CAS  PubMed  Article  Google Scholar 

Priego Moreno S, Jones RM, Poovathumkadavil D, Scaramuzza S, Gambus A. Mitotic replisome disassembly depends on TRAIP ubiquitin ligase activity. Life Sci Alliance. 2019;2:e201900390.

PubMed  PubMed Central  Article  Google Scholar 

Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Disco. 2017;16:203–22.

CAS  Article  Google Scholar 

Abdolvahabi Z, Nourbakhsh M, Hosseinkhani S, Hesari Z, Alipour M, Jafarzadeh M, et al. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53. J Cell Biochem. 2019;120:9356–68.

CAS  PubMed  Article  Google Scholar 

Cui X, Zhang X, Liu M, Zhao C, Zhang N, Ren Y, et al. A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors. Genomics. 2020;112:3958–67.

CAS  PubMed  Article  Google Scholar 

Chapard C, Hohl D, Huber M. The role of the TRAF-interacting protein in proliferation and differentiation. Exp Dermatol. 2012;21:321–6.

CAS  PubMed  Article  Google Scholar 

Wang C, Zhang R, Wang X, Zheng Y, Jia H, Li H, et al. Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/β-Catenin Signaling. Front Oncol. 2021;10:597464.

PubMed  PubMed Central  Article  Google Scholar 

Vanamee ÉS, Faustman DL. Structural principles of tumor necrosis factor superfamily signaling. Sci Signal. 2018;11:eaao4910.

PubMed  Article  Google Scholar 

Park HH. Structural feature of TRAFs, their related human diseases and therapeutic intervention. Arch Pharm Res. 2021;44:475–86.

CAS  PubMed  Article  Google Scholar 

Lee SY, Lee SY, Choi Y. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation. J Exp Med. 1997;185:1275–85.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Sajjad N, Mir MM, Khan J, Rather IA, Bhat EA. Recognition of TRAIP with TRAFs: Current understanding and associated diseases. Int J Biochem Cell Biol. 2019;115:105589.

CAS  PubMed  Article  Google Scholar 

Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-Analyzed Tumors. Cell. 2018;173:530.

CAS  PubMed  Article  Google Scholar 

Robinson MD, Smyth GK. Moderated statistical tests for assessing differences in tag abundance. Bioinformatics. 2007;23:2881–7.

CAS  PubMed  Article  Google Scholar 

Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–40.

CAS  PubMed  Article  Google Scholar 

Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.

PubMed  PubMed Central  Article